Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2026-08-07 16:34:44 ET · period of report 2026-08-01 · accession 0002144542-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 16:34 | 2026-08-01 | VKTX | Kelly-Gemmell Dorothy Elizabeth | Dir | A - Grant | $0.00 | +6,333 | 6,333 | New | $0 |
| D | 2026-08-07 16:34 | 2026-08-01 | VKTX | Kelly-Gemmell Dorothy Elizabeth | Dir | A - Grant | $0.00 | +40.8K | 40.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2026-08-01 | A | A | 6,333 | $0.00 | 6,333 | D | — | — | (F1) Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-01 | A | A | 40,800 | $0.00 | 40,800 | D | $31.74 · 2027-08-01 to 2036-08-01 | 40,800 Common Stock | (F2) One-third of the shares subject to the option will vest on each anniversary of the grant date. |